Clinical Trial Update: Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours [Phase 1]

View source ↗

Summary

A completed Phase 1 trial assessing pantoprazole in combination with doxorubicin in patients with advanced solid tumors, including an extension cohort.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Doxorubicin (doxorubicin)
• Pantoprazole (pantoprazole)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Advanced Solid Tumours | Phase 1 | Status: COMPLETED